Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biosite Triage ProfilER symptom panel

This article was originally published in The Gray Sheet

Executive Summary

Shipments of the "shortness-of-breath" test panel to distinguish among congestive heart failure, pulmonary embolism and heart attack will begin after the product debuts at the American Association for Clinical Chemistry annual meeting in Los Angeles July 25-29. Within 15 minutes, ER test-givers can measure five biomarkers: BNP, D-dimer, myoglobin, CK-MB and troponin I (1"The Gray Sheet" May 10, 2004, p. 23). The panel will "eliminate the need for the hospital to obtain multiple blood samples or employ one or more laboratory-based analyzers to accomplish multiple tests," Biosite states in a June 30 release announcing 510(k) clearance. The San Diego firm is emphasizing the assay's potential to combat "overcrowding" in emergency departments...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel